MC2 Therapeutics A/S: Financial statements 2012
CVR: 29526346
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 5,245,429 and a net result of DKK -31,328,487. Equity in the 2012 report amounted to DKK -288,903,719. The company had 4 employees in the financial year.
- Gross Profit
- DKK 5,245,429
- Profit/Loss
- DKK -31,328,487
- Equity
- DKK -288,903,719
- Total Assets
- DKK 6,806,434
- Employees
- 4
Official annual report
Keep an eye on MC2 Therapeutics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.